Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 16375

Columbus, OH 43213


Study Summary:

1222.51: A randomised, double blind, parallel group study to assess the efficacy and safety of 12 weeks of once daily, orally inhaled, co-administration of olodaterol 5 μg (delivered by the Respimat® Inhaler) and tiotropium 18 μg (delivered by the HandiHaler®) compared to once daily, orally inhaled, co-administration of placebo (delivered by the Respimat® Inhaler) and tiotropium 18 μg (delivered by the HandiHaler®) in patients with Chronic Obstructive Pulmonary Disease (COPD)


Qualified Participants Must:

• Be a current or former smoker
• Have trouble breathing or a persistent cough
• At least 40 years of age and healthy
• Have no significant heart conditions


Qualified Participants May Receive:

Medication and study-related medical care at no cost while participating in the study and reimbursement for certain study related travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.